NewsRx

Search our medical news database

Cancer Vaccines

Transloading Tumor Cells with a Foreign Peptide Generates A Potent Immune Response

Published in Gene Therapy Weekly, October 21st, 1996

Transloading of tumor cells with a foreign major histocompatibility complex (MHC) class I peptide overcomes the poor immunogenicity of cancer cells and creates a potent cancer vaccine.

The active immunotherapy of cancer is often blocked by the poor immunogenicity of cancer cells due to their 'self' origin. Studies in animal models have shown, however, that antitumor immunity can be overcome when expression of a foreign gene product is elicited in the tumor vaccine. Methods have included viral infection (W. Liebrich et al., Eur. J. Cancer, 1991;27:703-10) or transfection of a viral gene (E.R. Fearon et al., Cancer Res. 1988;48:2975-80).

Tumor cells...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook